{"id":"https://openalex.org/W4295067609","doi":"https://doi.org/10.1017/bca.2022.12","title":"Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research","display_name":"Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4295067609","doi":"https://doi.org/10.1017/bca.2022.12"},"language":"en","primary_location":{"id":"doi:10.1017/bca.2022.12","doi":"https://doi.org/10.1017/bca.2022.12","is_oa":true,"landing_page_url":"https://doi.org/10.1017/bca.2022.12","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/50B74320F4FC716FA2A470BDB510646E/S2194588822000124a.pdf/div-class-title-costs-and-benefits-of-branded-drugs-insights-from-cost-effectiveness-research-div.pdf","source":{"id":"https://openalex.org/S87209429","display_name":"Journal of Benefit-Cost Analysis","issn_l":"2152-2812","issn":["2152-2812","2194-5888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","erih-plus","jufo-1","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Benefit-Cost Analysis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/50B74320F4FC716FA2A470BDB510646E/S2194588822000124a.pdf/div-class-title-costs-and-benefits-of-branded-drugs-insights-from-cost-effectiveness-research-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113795849","display_name":"H. E. Frech","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154570441","display_name":"University of California, Santa Barbara","ror":"https://ror.org/02t274463","country_code":"US","type":"education","lineage":["https://openalex.org/I154570441"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. E. Frech","raw_affiliation_strings":["Department of Economics, University of California Santa Barbara, Santa Barbara, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Economics, University of California Santa Barbara, Santa Barbara, CA, USA","institution_ids":["https://openalex.org/I154570441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072048687","display_name":"Mark V. Pauly","orcid":"https://orcid.org/0000-0003-4957-4825","observed_orcids":["https://orcid.org/0000-0003-4957-4825"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark V. Pauly","raw_affiliation_strings":["Department of Health Care Management, University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Care Management, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020498828","display_name":"William S. Comanor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William S. Comanor","raw_affiliation_strings":["Department of Health Policy and Management, University of California Los Angeles, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Policy and Management, University of California Los Angeles, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075962053","display_name":"Joseph Martinez","orcid":"https://orcid.org/0000-0003-3491-2246","observed_orcids":["https://orcid.org/0000-0003-3491-2246"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph R. Martinez","raw_affiliation_strings":["Department of Health Care Management, University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Care Management, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5072048687"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":{"value":2920,"currency":"USD","value_usd":2920},"apc_paid":{"value":2920,"currency":"USD","value_usd":2920},"fwci":1.6092,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.87164293,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"13","issue":"2","first_page":"166","last_page":"181"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8062000274658203,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8062000274658203,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.19259999692440033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8600000143051147},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9010000228881836},{"id":"https://openalex.org/keywords/cost-per-qaly","display_name":"cost per QALY","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-prices","display_name":"drug prices","score":0.5759999752044678},{"id":"https://openalex.org/keywords/value-based-pricing","display_name":"value-based pricing","score":0.7570000290870667},{"id":"https://openalex.org/keywords/new-technology-adoption","display_name":"new technology adoption","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C198531522","wikidata":"https://www.wikidata.org/wiki/Q485146","display_name":"Sample (material)","level":2,"score":0.5644987225532532},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.554584264755249},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.45310327410697937},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.43236997723579407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4315963685512543},{"id":"https://openalex.org/C149782125","wikidata":"https://www.wikidata.org/wiki/Q160039","display_name":"Econometrics","level":1,"score":0.4143444895744324},{"id":"https://openalex.org/C129848803","wikidata":"https://www.wikidata.org/wiki/Q2564360","display_name":"Sample size determination","level":2,"score":0.4125615954399109},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.41254866123199463},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.3222516179084778},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.28121089935302734},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.2626885175704956},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.15093562006950378},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1017/bca.2022.12","doi":"https://doi.org/10.1017/bca.2022.12","is_oa":true,"landing_page_url":"https://doi.org/10.1017/bca.2022.12","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/50B74320F4FC716FA2A470BDB510646E/S2194588822000124a.pdf/div-class-title-costs-and-benefits-of-branded-drugs-insights-from-cost-effectiveness-research-div.pdf","source":{"id":"https://openalex.org/S87209429","display_name":"Journal of Benefit-Cost Analysis","issn_l":"2152-2812","issn":["2152-2812","2194-5888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","erih-plus","jufo-1","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Benefit-Cost Analysis","raw_type":"journal-article"},{"id":"pmh:oai:RePEc:cup:jbcoan:v:13:y:2022:i:2:p:166-181_2","doi":null,"is_oa":false,"landing_page_url":"https://www.cambridge.org/core/product/identifier/S2194588822000124/type/journal_article","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1017/bca.2022.12","doi":"https://doi.org/10.1017/bca.2022.12","is_oa":true,"landing_page_url":"https://doi.org/10.1017/bca.2022.12","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/50B74320F4FC716FA2A470BDB510646E/S2194588822000124a.pdf/div-class-title-costs-and-benefits-of-branded-drugs-insights-from-cost-effectiveness-research-div.pdf","source":{"id":"https://openalex.org/S87209429","display_name":"Journal of Benefit-Cost Analysis","issn_l":"2152-2812","issn":["2152-2812","2194-5888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","erih-plus","jufo-1","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Benefit-Cost Analysis","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4295067609.pdf","grobid_xml":"https://content.openalex.org/works/W4295067609.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1482016158","https://openalex.org/W1911616118","https://openalex.org/W1972305015","https://openalex.org/W1982069685","https://openalex.org/W1995827154","https://openalex.org/W2013610409","https://openalex.org/W2024584376","https://openalex.org/W2047690132","https://openalex.org/W2050670141","https://openalex.org/W2058056848","https://openalex.org/W2070031670","https://openalex.org/W2090806586","https://openalex.org/W2097554689","https://openalex.org/W2115175878","https://openalex.org/W2143401180","https://openalex.org/W2266168940","https://openalex.org/W2861428399","https://openalex.org/W2886176480","https://openalex.org/W2887324295","https://openalex.org/W2890681665","https://openalex.org/W2976699690","https://openalex.org/W3009985280","https://openalex.org/W3039642681","https://openalex.org/W3171395742","https://openalex.org/W3171636130"],"related_works":["https://openalex.org/W4394009658","https://openalex.org/W3015792696","https://openalex.org/W4255874807","https://openalex.org/W2948001735","https://openalex.org/W2090806586","https://openalex.org/W2077319315","https://openalex.org/W2140198689","https://openalex.org/W2767128726","https://openalex.org/W2990763479","https://openalex.org/W2084073221"],"abstract_inverted_index":{"Abstract":[0],"The":[1,76],"relationship":[2],"between":[3,66],"costs":[4,18,88,101],"and":[5,72,89,174],"health":[6,22],"benefits":[7,23,238],"of":[8,30,33,43,52,97,100,128,140,146,194,207,211,225,236],"branded":[9,34,83],"pharmaceuticals":[10,84,147,195],"remains":[11],"controversial.":[12],"This":[13,123],"paper":[14],"examines":[15],"the":[16,26,37,39,61,94,129,141,144,176,182,208,237],"incremental":[17,21,73],"incurred":[19],"for":[20],"gained":[24],"from":[25],"largest":[27],"available":[28],"sample":[29,78,132,171],"cost-effectiveness":[31],"studies":[32,47,65,81],"drugs":[35],"in":[36,63,117,131,143,157,196,218],"USA,":[38],"1994\u20132015":[40],"Tufts":[41],"Registry":[42],"Cost-Effectiveness":[44],"Analyses.":[45],"Earlier":[46],"used":[48],"small,":[49],"specialized":[50],"samples":[51],"drugs.":[53],"We":[54],"use":[55],"linear":[56],"regression":[57,124],"analysis":[58],"to":[59,93,161,169,175,214,231],"estimate":[60],"association":[62],"those":[64],"additional":[67,107],"quality-adjusted":[68],"life":[69],"years":[70],"(QALYs)":[71],"pharmaceutical":[74],"costs.":[75,133],"preferred":[77],"uses":[79],"476":[80],"involving":[82],"with":[85,113,155],"both":[86],"higher":[87],"increased":[90],"effectiveness":[91],"compared":[92],"previous":[95],"standard":[96],"care.":[98],"Regressions":[99],"on":[102,111,201],"QALYs":[103],"imply":[104],"that":[105,223],"an":[106],"QALY":[108,186,213],"is":[109],"associated,":[110],"average,":[112,202],"a":[114,138,212,234],"$28,561":[115],"increase":[116],"cost":[118,145,184],"(95":[119,189],"%":[120,127,190],"CI,":[121,191],"$18,853\u2013$38,270).":[122],"explains":[125],"20":[126],"variation":[130,142,156],"In":[134,179],"this":[135,197],"analytical":[136],"sample,":[137],"share":[139],"is,":[148],"therefore,":[149],"not":[150],"random":[151],"but":[152],"rather":[153],"associated":[154],"QALYs;":[158],"prices":[159],"are":[160,167],"some":[162],"extent":[163],"\u201cvalue-based.\u201d":[164],"Our":[165],"results":[166],"robust":[168],"varying":[170],"inclusion":[172],"criteria":[173],"funding":[177],"source.":[178],"subgroup":[180],"analyses,":[181],"highest":[183],"per":[185],"was":[187],"$44,367":[188],"$35,373\u2013$53,361).":[192],"Costs":[193],"data":[198],"set":[199],"are,":[200],"lower":[203],"than":[204],"common":[205],"estimates":[206],"monetary":[209],"value":[210],"American":[215],"consumers.":[216],"As":[217],"other":[219],"studies,":[220],"we":[221],"find":[222],"sellers":[224],"patent-protected":[226],"beneficial":[227],"new":[228],"technology":[229],"appear":[230],"capture":[232],"only":[233],"fraction":[235],"provided.":[239]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1}],"updated_date":"2026-08-28T12:50:07.497085","created_date":"2022-09-10T00:00:00"}